Literature DB >> 7718405

Molecular biology of the cyclic AMP-specific cyclic nucleotide phosphodiesterases: a diverse family of regulatory enzymes.

G B Bolger1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7718405     DOI: 10.1016/0898-6568(94)90018-3

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


× No keyword cloud information.
  36 in total

1.  Cyclic AMP levels, adenylyl cyclase activity, and their stimulation by serotonin quantified in intact neurons.

Authors:  L C Sudlow; R Gillette
Journal:  J Gen Physiol       Date:  1997-09       Impact factor: 4.086

2.  The novel distribution of phosphodiesterase-4 subtypes within the rat retina.

Authors:  C M Whitaker; N G F Cooper
Journal:  Neuroscience       Date:  2009-07-26       Impact factor: 3.590

3.  Stimulation of p70S6 kinase via a growth hormone-controlled phosphatidylinositol 3-kinase pathway leads to the activation of a PDE4A cyclic AMP-specific phosphodiesterase in 3T3-F442A preadipocytes.

Authors:  S J MacKenzie; S J Yarwood; A H Peden; G B Bolger; R G Vernon; M D Houslay
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-31       Impact factor: 11.205

4.  The SH3 domain of Src tyrosyl protein kinase interacts with the N-terminal splice region of the PDE4A cAMP-specific phosphodiesterase RPDE-6 (RNPDE4A5).

Authors:  J C O'Connell; J F McCallum; I McPhee; J Wakefield; E S Houslay; W Wishart; G Bolger; M Frame; M D Houslay
Journal:  Biochem J       Date:  1996-08-15       Impact factor: 3.857

5.  Receptor-mediated stimulation of lipid signalling pathways in CHO cells elicits the rapid transient induction of the PDE1B isoform of Ca2+/calmodulin-stimulated cAMP phosphodiesterase.

Authors:  S Spence; G Rena; M Sullivan; S Erdogan; M D Houslay
Journal:  Biochem J       Date:  1997-01-01       Impact factor: 3.857

6.  Action of rolipram on specific PDE4 cAMP phosphodiesterase isoforms and on the phosphorylation of cAMP-response-element-binding protein (CREB) and p38 mitogen-activated protein (MAP) kinase in U937 monocytic cells.

Authors:  S J MacKenzie; M D Houslay
Journal:  Biochem J       Date:  2000-04-15       Impact factor: 3.857

Review 7.  Phosphodiesterase 4 inhibitors and the treatment of asthma: where are we now and where do we go from here?

Authors:  M A Giembycz
Journal:  Drugs       Date:  2000-02       Impact factor: 9.546

8.  Molecular cloning and transient expression in COS7 cells of a novel human PDE4B cAMP-specific phosphodiesterase, HSPDE4B3.

Authors:  E Huston; S Lumb; A Russell; C Catterall; A H Ross; M R Steele; G B Bolger; M J Perry; R J Owens; M D Houslay
Journal:  Biochem J       Date:  1997-12-01       Impact factor: 3.857

9.  Mapping binding sites for the PDE4D5 cAMP-specific phosphodiesterase to the N- and C-domains of beta-arrestin using spot-immobilized peptide arrays.

Authors:  George S Baillie; David R Adams; Narinder Bhari; Thomas M Houslay; Suryakiran Vadrevu; Dong Meng; Xiang Li; Allan Dunlop; Graeme Milligan; Graeme B Bolger; Enno Klussmann; Miles D Houslay
Journal:  Biochem J       Date:  2007-05-15       Impact factor: 3.857

Review 10.  ABCD of the phosphodiesterase family: interaction and differential activity in COPD.

Authors:  David M G Halpin
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2008
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.